搜索筛选:
搜索耗时0.0775秒,为你在为你在102,285,761篇论文里面共找到 7 篇相符的论文内容
发布年度:
[会议论文] 作者：Hyun Moo KoH,Young Suk PARK,Yang Hee JOE,
来源：2009武汉国际桥梁科技论坛 年份：2009
在相对较短的时间里，韩国的桥梁建设技术已经取得了显著的发展。由于政府的政策目标是实现地区均衡发展，半岛的桥梁建设是前所未有的，特别是在西南沿海的3000岛屿与内地的连接。......
Nutritional safety and metabolic benefits of long limb uncut Roux-en Y gastrojejunostomy for obese g
[会议论文] 作者：Young Suk Park,Do Joong Park,Yoontaek Lee,Dong Wook Kim,Sang-Hoon Ahn,Hyung-Ho Kim,
来源：第十二届国际胃癌学术会议 年份：2017
...
[会议论文] 作者：Sang-Yong Son,Hye Seung Lee,Yoontaek Lee,Dong-Wook Kim,Young Suk Park,Sang-Hoon AhnDo Joong Park,Do Joong,
来源：第十二届国际胃癌学术会议 年份：2017
...
Predicting tumor response after preoperative chemoradiation using clinical parameters in rectal canc
[期刊论文] 作者：Chan Ho Park,Hee Cheol Kim,Yong Beom Cho,Seong Hyeon Yun,Woo Yong Lee,Young Suk Park,Doo Ho Choi,Ho-Kyung,
来源：World Journal of Gastroenterology 年份：2011
AIM: To evaluate the clinical parameters and identify a better method of predicting pathological complete response (pCR). METHODS: We enrolled 249 patients from...
Study protocol of the Asian XELIRI ProjecT(AXEPT):a multinational,randomized,non-inferiority,phase Ⅲ
[期刊论文] 作者：Masahito Kotaka,Ruihua Xu,Kei Muro,Young Suk Park,Satoshi Morita,Satoru Iwasa,Hiroyuki Uetake,Tomohiro,
来源：Chinese Journal of Cancer 年份：2016
Background: Capecitabine and irinotecan combination therapy(XELIRI) has been examined at various dose levels to treat metastatic colorectal cancer(m CRC). Recen...
[期刊论文] 作者：Sung-Hyun Kim,Hyuk-Chan Kwon,Gyeong-Won Lee,Jung Hun Kang,In Gyu Hwang,Joung-Soon Jang,Ho Yeong Lim,Young Suk Park,
来源：World Journal of Gastroenterology 年份：2009
AIM: To identify the clinical features and outcomes of infrequently reported leptomeningeal carcinomatosis (LMC) of gastric cancer.METHODS: We analyzed 54 cases...
[会议论文] 作者：,Rico King-yin LIU,Brigette Ma,Shailesh V.Shrikhande,S.P.Somasekhar,Sun Young Kim,Tae Won Kim,Young Suk Park,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Colorectal cancer (CRC) is currently the fourth most common cause of cancer death worldwide.Approximately 50% of patients develop distant metastases in the liver, which is the most common site; approx...
相关搜索：
